QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Activity

9 hedge funds and large institutions have $8.6M invested in Qualigen Therapeutics in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BC
1
Broadfin Capital
New York
$3.46M
2
HCMT
2
Highland Capital Management (Texas)
Texas
$2.53M
3
BBA
3
Baker Bros. Advisors
New York
$1.78M
4
Millennium Management
4
Millennium Management
New York
$369K
5
SCM
5
Sterling Capital Management
North Carolina
$111K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
BC
1
Broadfin Capital
New York
$3.46M 778,000 +778,000 New
HCMT
2
Highland Capital Management (Texas)
Texas
$2.53M 567,317 +567,317 New
BBA
3
Baker Bros. Advisors
New York
$1.78M 400,000 +400,000 New
Millennium Management
4
Millennium Management
New York
$369K 82,850 +82,850 New
SCM
5
Sterling Capital Management
North Carolina
$111K 25,165 +25,165 New
SEP
6
Sound Energy Partners
Connecticut
$89K 20,000 +20,000 New
TMC
7
Trellus Management Company
Florida
$89K 20,000 +20,000 New
Goldman Sachs
8
Goldman Sachs
New York
$89K 20,000 +20,000 New
Citadel Advisors
9
Citadel Advisors
Florida
$85K 19,082 +19,082 New